Otero-Romero, S; Rodríguez-García, J; Vilella, A; Ara, J-R; Brieva, L; Calles, C; Carmona, O; Casanova, V; Costa-Frossard, Lucienne; Eichau, S; García-Merino, J-A; García-Vidal, C; González-Platas, M; Llaneza, M; Martínez-Gines, M; Meca-Lallana, José-Eustasio; Prieto, J-M; Rodríguez-Antigüedad, Alfredo; Tintore, M; Blanco, Y; Moral, E
(ELSEVIER ESPANA SLU, 2021-01)
BACKGROUND: The recent development of highly effective treatments for multiple sclerosis (MS) and the potential risk of infectious complications require the development of prevention and risk minimisation strategies. ...